FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to chemical-pharmaceutical industry, namely to creation of antituberculous composite medication, which contains isoniaside and individual glycoside of plant Stevia rebaudiana - stevioside or steviolbioside or mixture of said plant glycosides, which represent sweetener.
EFFECT: medication reduces toxicity of antituberculous medication isoniaside.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DIMEPHOSPHONE NICOTINOYLHYDRAZONE POSSESSING ANTI-TUBERCULOSIS ACTIVITY | 2011 |
|
RU2471787C1 |
| METHOD OF PRODUCING 16(S)-DIHYDROSTEVIOL | 2011 |
|
RU2448947C1 |
| COMBINED ANTITUBERCULOUS DRUGS | 2013 |
|
RU2545731C1 |
| DIMEPHOSPHONE ISONICOTINOYLHYDRAZONE WITH ANTI-TUBERCULOSIS ACTIVITY | 2011 |
|
RU2457212C1 |
| DIALKYL(2-METHYL-4-OXOPENT-2-YL)PHOSPHINE OXIDE PYRIDINOYL HYDRAZONES, HAVING ANTITUBERCULOUS ACTIVITY | 2012 |
|
RU2498990C1 |
| SALT OF BIS(OXYMETHYL)PHOSPHINIC ACID WITH ISONICOTINIC ACID HYSRAZIDE (TUBOPHEN) HAVING ANTITUBERCULOSIS ACTION AND METHOD FOR PRODUCTION THEREOF | 2005 |
|
RU2281939C1 |
| TRAIZINES HAVING ANTI-TUBERCULOSIS ACTIVITY | 2010 |
|
RU2431633C1 |
| 5-FLUORO-2-(4-ETHOXYCARBONYLDIPIPERAZINE-1-YL)-1,3-BENZOTHIAZINE-4-ONE, WHICH HAS ANTI-TUBERCULOSIS ACTIVITY | 2018 |
|
RU2663848C1 |
| 1-ETHYL-6-FLUORO-4-OXO-7-(8-ETHOXY-2-OXO-2H-CHROMEN-3-YL)-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID WITH ANTI-TUBERCULAR ACTIVITY | 2017 |
|
RU2642426C1 |
| β-CARBOLINE DERIVATIVES, POSSESSING ANTI-TUBERCULOSIS ACTIVITY, THEIR APPLICATION FOR MEDICATION MANUFACTURING, METHOD OF THEIR SYNTHESIS, AS WELL AS NOVEL METHODS OF TREATMENT WITH THEIR APPLICATION | 2010 |
|
RU2419431C1 |
